Back to Search Start Over

Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Rapid Recommendation Q and A.

Authors :
Garje, Rohan
Hope, Thomas A.
Rumble, R. Bryan
Parikh, Rahul A.
Source :
JCO Oncology Practice; Mar2023, Vol. 19 Issue 3, p132-135, 4p
Publication Year :
2023

Abstract

The article presents answers to questions related to lutetium-177-PSMA-617 therapy for metastatic castration-resistant prostate cancer based on a randomized controlled trial.

Subjects

Subjects :
RADIATION protection
METASTASIS
TRANSITION metals
CASTRATION-resistant prostate cancer
RADIOPHARMACEUTICALS
RADIATION doses
PROSTATE-specific antigen
DNA damage

Details

Language :
English
ISSN :
26881527
Volume :
19
Issue :
3
Database :
Complementary Index
Journal :
JCO Oncology Practice
Publication Type :
Academic Journal
Accession number :
162363844
Full Text :
https://doi.org/10.1200/OP.22.00753
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details